'A comprehensive personal health agent that reasons over multimodal data from consumer wellness devices and medical records to provide personalized health support.' nature.com/articles/s41586-0…

Why does the time of day you get immunotherapy matter? Early studies suggested morning infusions drastically improve survival for cancer patients. But the field still lacks definitive randomized evidence—and a recent major retraction highlights why. The Catch with Retrospective Data •Frailty Bias: Healthier patients get morning slots; frailer patients often face delays into the afternoon. •Drug Half-Life: Immune checkpoint inhibitors stay active in the body for weeks. Does the exact hour of infusion really change the long-term outcome? The Randomized Reality •Major Retraction: The phase III LungTIME-C01 trial initially showed a massive advantage for morning dosing but was retracted in June 2026 due to protocol and data discrepancies. •Conflicting Data: Large pooled analyses (like i-TIMES) show no meaningful survival difference between early and late infusions. •Logistics: Standardizing morning-only dosing would create massive bottlenecks in oncology clinics worldwide. Chronotherapy holds immense biological promise, but we need bulletproof, prospective randomized trials before rewriting clinical guidelines. #CancerResearch #Immunotherapy #Oncology #MedEd Time-of-Day Immunotherapy: Why the Field Still Needs Randomized Evidence | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…

DYK? Facial imaging and AI could work together for predicting cancer outcomes. Researchers have developed an AI model, FAHR-FaceSurvival, that analyses facial images to estimate mortality risk in people with cancer. The model builds on AI-based biological age estimation, potentially detecting subtle features associated with ageing and physical resilience that may not be apparent to the naked eye. Could this non-invasive approach one day help clinicians personalise cancer treatment? Promising science—but not yet ready for routine clinical use. Further validation across diverse populations is essential to establish accuracy, fairness and clinical value. #CancerResearch #ArtificialIntelligence #DigitalHealth #PrecisionOncology

AI & Digital Pathways: Making Technology Work for Everyone AI is transforming how we live, work and access services. But the real opportunity lies not just in adopting technology, but in making it accessible, trusted and meaningful for everyone. The future of digital transformation must be inclusive, human-centred and driven by real-world impact. #AI #DigitalTransformation #DigitalInclusion #Innovation #India

Wednesday Myth Buster | Survivor’s Solitude, Voices of Support MYTH: Once cancer treatment ends, survivors can return to normal life. REALITY: After treatment, survivors may face ongoing health concerns, workplace barriers, emotional distress, and isolation. They need support—not just sympathy. Cancer survivorship is about more than surviving. It’s about living with dignity, confidence, and connection. Let’s make cancer survivor support programs a priority in hospitals, workplaces, and communities. Share this post and help amplify survivors’ voices. #MondayMythBuster #CancerSurvivorship #CancerCare #SurvivorSupport.

Tuesday Myth Buster | Survivor’s Solitude, Voices of Support MYTH: Once cancer treatment ends, survivors return to normal life. REALITY: The end of treatment doesn't always mean the end of challenges. Survivors may face ongoing health concerns, workplace barriers, emotional distress, and isolation. Cancer survivorship is more than survival—it’s about living with dignity, confidence, and support. Let’s make survivor support programs a priority in hospitals, workplaces, and communities. Share this post and help amplify survivors’ voices. #MondayMythBuster #CancerSurvivorship #CancerCare #SurvivorSupport

Monday Myth Buster | Survivor’s Solitude, Voices of Support MYTH: Once cancer treatment ends, survivors can return to normal life. REALITY: Survivorship can bring lasting challenges—health concerns, workplace barriers, emotional distress, and isolation. The end of treatment doesn't mean the end of support needs. Cancer survivors deserve more than congratulations. They deserve care, understanding, and ongoing support. CALL TO ACTION: Let’s make cancer survivor support programs a priority—in hospitals, workplaces, and communities. Share this post and help amplify survivors’ voices. #MondayMythBuster #CancerSurvivorship #CancerCare #SurvivorSupport

The Rising Burden of Cancer Care in India With 1.56 million new cases and 900,000 deaths annually, cancer remains one of India's most urgent health and economic challenges. Key figures from recent coverage: • 60 people per 1 lakh affected by cancer • ₹7.5 lakh average treatment cost per patient • 70%–80% paid directly out-of-pocket • Hospital markups on non-scheduled drugs reaching up to 700% Proposed 30% trade margin caps aim to curb excessive markups, but experts emphasize that broader pricing policies are needed to address high base costs for essential life-saving therapies. #HealthPolicy #CancerCare #HealthcareIndia #PublicHealth #AffordableCare .

India has already achieved a 21% drop in TB incidence and a 92% treatment coverage rate, outpacing global averages. Joint Squad for Health (JOSH) initiative has been launched. This massive grassroots mobilization under the TB Mukt Bharat Abhiyaan unites thousands of MY Bharat volunteers and NCC cadets to eliminate TB once and for all. The Power of JOSH: 58,000+ youth volunteers activated 55 districts covered in 11 states/UTs in Phase 1 Jointly driven by Health, Youth Affairs, and Defence ministries Together, our youth are leading the charge toward a healthier tomorrow. pib.gov.in/PressReleasePage.…

Dairy may actually be preventing certain cancers, rather than causing them.

Cervavac vaccine for HPV-caused cancers is approved by the Drugs Controller General of India (DCGI) and prequalified by the World Health Organization (WHO), but it is officially licensed and recommended for a multi-dose schedule rather than a single dose. Approved Dosing Schedules for Cervavac: Ages 9 to 14 years: Administered in a 2-dose schedule (at 0 and 6 months). Ages 15 to 26 years: Administered in a 3-dose schedule (at 0, 2, and 6 months). Regulatory Status: DCGI Approval: The official Summary of Product Characteristics (SmPC) approved by India's regulatory authority specifies either a 2-dose or 3-dose regimen depending on age. While the WHO has broader global guidelines acknowledging single-dose options for certain HPV vaccines, Cervavac itself is formally evaluated and indicated for 2 or 3 doses by the manufacturer (Serum Institute of India) and regulators. WHO Prequalification: WHO prequalification allows the vaccine to be procured globally through UN agencies, and global discussions on single-dose efficacy continue, but standard clinical and national guidelines still mandate completing the full 2-dose or 3-dose course. @chipfoundation

A cancer survivor's journey after completing treatment involves physical healing, emotional adjustment, and establishing a new normal. Phases of Survivorship Extended Survivorship: Begins immediately after treatment ends. Focuses on adjusting to life post-cancer, managing side effects, and attending ongoing medical monitoring. Permanent Survivorship: Continues for the rest of the survivor's life as long-term wellness and periodic screenings take priority.#Cancer #Survivorship #Familysupport @chipfoundation

The recent @TheLancet Commission on 21st Century Global Threats ranks obesity as the top cumulative threat to global health through 2100 ranks obesity as No. 1! Cumulative Burden: Obesity (defined as a cluster of high body mass index [BMI], poor diet, and low physical activity) accounts for an estimated 23.1 billion cumulative amenable Disability-Adjusted Life Years (DALYs) between 2025 and 2100. Top Tier Threats: The Commission organizes major catastrophic threats in a tiered structure rather than a simple linear list. Obesity leads the major risks alongside other critical forces like low educational attainment (16.1 billion DALYs) and income inequality (13.8 billion DALYs). Comparison: For scale, the cumulative expected burden of obesity far exceeds historical benchmarks such as the COVID-19 pandemic, which generated roughly 500 million DALYs. Other Major Risks: The list of 15 major catastrophic threats also includes antimicrobial resistance, air pollution, climate change, poor mental health, and smoking. @chipfoundation thelancet.com/journals/lance…

DYK: 1 in 8 cancers are infection-related. Vaccinations are available for many infection-related cancers. @sciam - excellent infographic. scientificamerican.com/artic…